Curated News
By: NewsRamp Editorial Staff
August 25, 2026
India's Medical Device Market Boom: A Golden Opportunity for SS Innovations
TLDR
- India's medical-device market surge to $50B by 2030 gives SSII a strategic edge in expanding global sales.
- SS Innovations' SSi Mantra, installed in 12 countries, leverages India's growth to pursue FDA and CE certifications.
- India's medical-device growth and SSII's expansion promise improved healthcare access and technology worldwide.
- India's medical-device market may outpace IT, with SSII's robotic systems at the forefront.
Impact - Why it Matters
India's projected medical-device market growth to $50.1 billion by 2030 signals a major shift in global manufacturing dynamics. For investors and industry stakeholders, this represents a ripe opportunity to capitalize on a high-growth sector. For SS Innovations, the alignment of India's push for self-reliance in medical devices with its existing surgical robotic platform positions it to capture significant market share, both domestically and internationally. As India reduces import dependence, companies like SSII could see accelerated adoption of their technologies, potentially reshaping the competitive landscape of surgical robotics and medical device manufacturing worldwide.
Summary
India is on the cusp of a medical-device manufacturing boom, with the market projected to surge from $15.2 billion in 2025 to $50.1 billion by 2030, a compound annual growth rate of 26.9%. This growth, highlighted in a report from Rubix Industry Insights and cited by business developer Shaad Merchant, positions medical devices as one of India's fastest-growing industrial and healthcare sectors. The expansion presents a significant opportunity for domestic manufacturers to meet both local demand and export needs, reducing reliance on imports.
A key player poised to benefit is SS Innovations International (NASDAQ: SSII), which is already commercializing its SSi Mantra surgical robotic system from its Indian base. By June 30, the company had installed 224 SSi Mantra systems across 12 countries, demonstrating an established platform for growth. India's push to boost domestic MedTech manufacturing could open doors for SSII beyond domestic sales, including manufacturing, exports, and international technology adoption. The company is actively pursuing US FDA clearance and European Union CE mark certification to expand its flagship product globally, signaling its ambition to be a major global player.
For more details, read the full story at Read More>>. Investors can stay updated on SSII news via the company's newsroom at https://ibn.fm/SSII. This report is distributed by InvestorWire, part of the Dynamic Brand Portfolio @ IBN, offering comprehensive corporate communications solutions.
Source Statement
This curated news summary relied on content distributed by InvestorBrandNetwork (IBN). Read the original source here, India's Medical Device Market Boom: A Golden Opportunity for SS Innovations
